Oral blistering diseases

Clinics in Dermatology

Volumn 18, Issue 5, 2000, Pages 513-523

  Bowers, Kathryn E ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; AZATHIOPRINE; CAPTOPRIL; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; ERYTHROMYCIN; FAMCICLOVIR; GOLD; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LEVAMISOLE; METHOTREXATE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINAMIDE; PENICILLAMINE; PREDNISONE; STEROID; TETRACYCLINE; THALIDOMIDE; THIOL DERIVATIVE; VALACICLOVIR;

BLISTER; CLINICAL FEATURE; DERMATITIS HERPETIFORMIS; EPIDERMOLYSIS BULLOSA; EPIDERMOLYSIS BULLOSA ACQUISITA; ERYTHEMA MULTIFORME; GINGIVITIS; HUMAN; MOUTH DISEASE; MUCOUS MEMBRANE PEMPHIGOID; PATHOGENESIS; PEMPHIGOID; PEMPHIGUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; REVIEW; SKIN DISEASE;

HUMANS; MOUTH DISEASES; MOUTH MUCOSA; PROGNOSIS; SKIN DISEASES, VESICULOBULLOUS;

EID: 0034633114     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(00)00141-3     Document Type: Review

References (81)

1. New and emerging therapies for diseases of the oral cavity
2. New and emerging therapies in the treatment of blistering diseases
3. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders
4. Erythema multiforme involving gingival
5. Examination of non-involved skin, previously involved skin, and peripheral blood for herpes simplex virus DNA in patients with recurrent herpes-associated erythema multiforme
6. A double-blind placebo-controlled trial of continuous acyclovir in recurrent erythema multiforme
7. Recurrent erythema multiforme: Clinical features and treatment in a large series of patients
8. Thalidomide therapy. An open trial
9. Oral pemphigus vulgaris
10. Oral presentation of pemphigus vulgaris and its response to systemic steroid therapy
11. Oral manifestations and treatment of pemphigus vegetans
12. Cerebriform tongue - A clinical sign in pemphigus vegetans
13. Drug-induced pemphigus
14. Paraneoplastic pemphigus: An autoimmune mucocutaneous disease associated with neoplasia
15. Antibodies against desmoglein-3 are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice
16. Desmoglein 3-ELISA: A pemphigus vulgaris-specific diagnostic tool
17. An electron microscopic study on pemphigus vulgaris of the mouth and the skin with special reference to the intercellular cement
18. Pemphigus in remission: Value of negative direct immunofluorescence in management
19. Pemphigus vulgaris: The manifestations and long-term management of 55 patients with oral lesions
20. The treatment of pemphigus vulgaris. Experience with 48 patients seen over an 11-year period
21. Pemphigus vulgaris in older adults
22. Immune-mediated subepithelial blistering diseases of mucous membranes. Pure ocular cicatricial pemphigoid is a unique clinical and immunopathological entity distinct from bullous pemphigoid and other subsets identified by antigenic specificities of autoantibodies
23. Immunopathology of oral mucosal ulcerative, desquamative and bullous diseases
24. Cicatricial pemphigoid
25. Cicatricial pemphigoid
26. Salt-split human skin substrate for the immunofluorescent screening of serum from patients with cicatricial pemphigoid and a new method of immunoprecipitation with IgA antibodies
27. Immune-mediated subepithelial blistering diseases of the mucous membranes: Improving the detection of circulating autoantibodies by the use of concentrated sera
28. Mucous membrane pemphigoid: A dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease
29. Anti-epiligrin cicatricial pemphigoid, a subepithelial basement membrane disorder
30. Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5
31. Anti-epiligrin cicatricial pemphigoid: A case associated with gastric carcinoma and features resembling epidermolysis bullosa acquisita
32. Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid
33. Ocular cicatricial pemphigoid antigen: Partial sequence and biochemical characterization
34. Clinical variations in bullous pemphigoid with respect to early symptoms
35. Mucosal involvement in bullous and cicatricial pemphigoid. A clinical and immunopathological study
36. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profile
37. Bullous pemphigoid: Clinical and immunologic follow-up after successful therapy
38. Correlation of pemphigoid and pemphigus antibody titers and disease activity
39. The treatment of bullous pemphigoid with tetracycline and niacinamide
40. Clinical, histological and immunological studies in 50 patients with bullous pemphigoid
41. Vital prognosis in bullous pemphigoid: A cohort analysis of 78 patients
42. Anti-BP 180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: A cohort analysis of 94 elderly patients
43. Increased incidence of malignancy in dermatitis herpetiformis
44. Diseases associated with dermatitis herpetiformis
45. Chronic bullous disease of childhood, childhood cicatricial pemphigoid and linear IgA disease of adults
46. Linear IgA bullous dermatosis
47. Vancomycin-associated linear IgA dermatosis
48. A clinicopathological study of mucosal involvement in linear IgA disease
49. Linear IgA disease manifesting as recalcitrant desquamative gingivitis
50. Intercellular IgA vesiculopustular dermatosis: An additional case and a review of the literature
51. Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin-A bullous dermatosis
52. The 97-kD linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180-kDa bullous pemphigoid antigen, BPAG2
53. Interferon-alpha for linear IgA bullous dermatosis
54. Chronic bullous disease of childhood: Successful treatment with dicloxacillin
55. Hereditary epidermolysis bullosa
56. Oral soft tissues in hereditary epidermolysis bullosa
57. Oral and gastrointestinal manifestations of epidermolysis bullosa
58. Epidermolysis bullosa dystrophica with epidermal neoplasms
59. Dental caries risk in hereditary epidermolysis bullosa
60. Salivary function of persons with hereditary epidermolysis bullosa
61. Epidermolysis bullosa complicated by squamous cell carcinoma: Report of 10 cases
62. Comprehensive dental care and general anesthetic management of hereditary epidermolysis bullosa: A review of 14 cases
63. Increased frequencies of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: Evidence that autoimmunity to type VII collagen is HLA class II allele associated
64. Epidermolysis bullosa acquisita in identical twins
65. Epidermolysis bullosa acquisita: Report of three cases and review of all published cases
66. Epidermolysis bullosa acquisita: A heterogeneous disease
67. The spectrum of epidermolysis bullosa acquisita
68. Severe ocular involvement in a patient with epidermolysis bullosa acquisita
69. Epidermolysis bullosa acquisita and other acquired blistering diseases manifesting autoimmunity to type VII collagen
70. Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid)
71. Diagnostic value of indirect immunofluorescence on sodium chloride split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses
72. Identification of the skin basement membrane autoantigen in epidermolysis bullosa acquisita
73. Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy
74. Oral blood blisters, angina bullosa haemorrhagica
75. Angina bullosa haemorrhagica: Clinical and laboratory findings in 30 patients
76. Blood blisters of the oral mucosa (angina bullosa hemorrhagica)